Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.

IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY
Carmen Gasca-Salas, Sarah Duff-Canning, Eric McArthur, Melissa J Armstrong, Susan Fox, Christopher A Meaney, David F Tang-Wai, David Gill, Paul J Eslinger, Cindy Zadikoff, Fred J Marshall, Mark Mapstone, Kelvin L Chou, Carol Persad, Irene Litvan, Benjamin T Mast, Adam T Gerstenecker, Sandra Weintraub, Connie Marras
{"title":"Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.","authors":"Carmen Gasca-Salas, Sarah Duff-Canning, Eric McArthur, Melissa J Armstrong, Susan Fox, Christopher A Meaney, David F Tang-Wai, David Gill, Paul J Eslinger, Cindy Zadikoff, Fred J Marshall, Mark Mapstone, Kelvin L Chou, Carol Persad, Irene Litvan, Benjamin T Mast, Adam T Gerstenecker, Sandra Weintraub, Connie Marras","doi":"10.1097/WAD.0000000000000576","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mild cognitive impairment is common in Parkinson disease (PD-MCI). However, instability in this clinical diagnosis and variability in rates of progression to dementia raises questions regarding its utility for longitudinal tracking and prediction of cognitive change in PD. We examined baseline neuropsychological test and cognitive diagnosis predictors of cognitive change in PD.</p><p><strong>Methods: </strong>Persons with PD, without dementia PD (N=138) underwent comprehensive neuropsychological assessment at baseline and were followed up to 2 years. Level II Movement Disorder Society criteria for PD-MCI and PD dementia (PDD) were applied annually. Composite global and domain cognitive z -scores were calculated based on a 10-test neuropsychological battery.</p><p><strong>Results: </strong>Baseline diagnosis of PD-MCI was not associated with a change in global cognitive z -scores. Lower baseline attention and higher executive domain z -scores were associated with greater global cognitive z -score worsening regardless of cognitive diagnosis. Worse baseline domain z -scores in the attention and language domains were associated with progression to MCI or PDD, whereas higher baseline scores in all cognitive domains except executive function were associated with clinical and psychometric reversion to \"normal\" cognition.</p><p><strong>Conclusions: </strong>Lower scores on cognitive tests of attention were predictive of worse global cognition over 2 years of follow-up in PD, and lower baseline attention and language scores were associated with progression to MCI or PDD. However, PD-MCI diagnosis per se was not predictive of cognitive decline over 2 years. The association between higher executive domain z -scores and greater global cognitive worsening is probably a spurious result.</p>","PeriodicalId":7679,"journal":{"name":"Alzheimer Disease & Associated Disorders","volume":" ","pages":"335-342"},"PeriodicalIF":1.8000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer Disease & Associated Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WAD.0000000000000576","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mild cognitive impairment is common in Parkinson disease (PD-MCI). However, instability in this clinical diagnosis and variability in rates of progression to dementia raises questions regarding its utility for longitudinal tracking and prediction of cognitive change in PD. We examined baseline neuropsychological test and cognitive diagnosis predictors of cognitive change in PD.

Methods: Persons with PD, without dementia PD (N=138) underwent comprehensive neuropsychological assessment at baseline and were followed up to 2 years. Level II Movement Disorder Society criteria for PD-MCI and PD dementia (PDD) were applied annually. Composite global and domain cognitive z -scores were calculated based on a 10-test neuropsychological battery.

Results: Baseline diagnosis of PD-MCI was not associated with a change in global cognitive z -scores. Lower baseline attention and higher executive domain z -scores were associated with greater global cognitive z -score worsening regardless of cognitive diagnosis. Worse baseline domain z -scores in the attention and language domains were associated with progression to MCI or PDD, whereas higher baseline scores in all cognitive domains except executive function were associated with clinical and psychometric reversion to "normal" cognition.

Conclusions: Lower scores on cognitive tests of attention were predictive of worse global cognition over 2 years of follow-up in PD, and lower baseline attention and language scores were associated with progression to MCI or PDD. However, PD-MCI diagnosis per se was not predictive of cognitive decline over 2 years. The association between higher executive domain z -scores and greater global cognitive worsening is probably a spurious result.

帕金森病患者认知变化的预测因素:一项为期2年的随访研究
背景:轻度认知障碍在帕金森病(PD-MCI)中很常见。然而,这种临床诊断的不稳定性和痴呆进展率的可变性引发了人们对其在PD患者认知变化的纵向跟踪和预测中的应用的质疑。我们检查了PD患者认知改变的基线神经心理测试和认知诊断预测指标。方法:对PD患者(N=138)在基线时进行综合神经心理学评估,随访2年。II级运动障碍协会标准的PD- mci和PD痴呆(PDD)每年应用。综合整体和领域认知z分数是基于10个测试的神经心理学电池计算的。结果:PD-MCI的基线诊断与总体认知z评分的变化无关。无论认知诊断如何,较低的基线注意力和较高的执行域z分数与更大的整体认知z分数恶化有关。注意和语言领域较差的基线z域得分与MCI或PDD的进展有关,而除执行功能外所有认知领域较高的基线得分与临床和心理测量回归到“正常”认知有关。结论:较低的注意力认知测试得分预示着PD患者在随访2年后整体认知能力变差,较低的基线注意力和语言得分与MCI或PDD的进展有关。然而,PD-MCI诊断本身并不能预测2年后的认知能力下降。更高的执行域z分数与更严重的全球认知恶化之间的联系可能是一个虚假的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
4.80%
发文量
88
期刊介绍: ​Alzheimer Disease & Associated Disorders is a peer-reviewed, multidisciplinary journal directed to an audience of clinicians and researchers, with primary emphasis on Alzheimer disease and associated disorders. The journal publishes original articles emphasizing research in humans including epidemiologic studies, clinical trials and experimental studies, studies of diagnosis and biomarkers, as well as research on the health of persons with dementia and their caregivers. The scientific portion of the journal is augmented by reviews of the current literature, concepts, conjectures, and hypotheses in dementia, brief reports, and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信